Completed NA INTERVENTIONAL 2-arm NCT02611401

Efficacy of MBI for Depressive Symptoms in Patients With MS

The Efficacy of a Mindfulness Based Intervention for Depressive Symptoms in Patients With Multiple Sclerosis and Their Caregivers. A Randomized Controlled Clinical Trial.

Sponsor: Fondazione Italiana Sclerosi Multipla

Conditions Depression Multiple Sclerosis

Interventions Mindfulness Psychoeducation

Updated 7 times since 2017 Last updated: Sep 5, 2018 Started: May 31, 2014 Primary completion: Dec 31, 2016 Completion: May 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Depression and Multiple Sclerosis and is currently completed. Fondazione Italiana Sclerosi Multipla leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2018 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE4 → NA
Jun 2018 — Oct 2018 [monthly]

Unknown Status PHASE4

▶ Show 2 earlier versions

Feb 2018 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Recruiting PHASE4

First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione Italiana Sclerosi Multipla
University of Turin, Italy

Data source: University of Turin, Italy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Orbassano, Italy